← Back to Search

Corticosteroid

Amino Acid Group for Atopic Dermatitis

Phase 3
Waitlist Available
Led By Alexandra Kimball, MD
Research Sponsored by NeoStrata Company, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 5 weeks
Awards & highlights

Study Summary

The purpose of this study is to compare the effects of an amino acid moisturizing cream and desonide cream in reducing skin symptoms associated with AD/eczema in subjects with mild to moderate atopic dermatitis/eczema.

Eligible Conditions
  • Atopic Dermatitis

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~5 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 5 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in skin effects of an amino acid moisturizing cream and desonide cream in reducing skin symptoms associated with AD/eczema in subjects with mild to moderate atopic dermatitis/eczema.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Amino Acid GroupExperimental Treatment1 Intervention
Group randomly receiving amino acid moisturizing cream as the treatment cream for 3 weeks. Fifteen (15) gram tubes are dispensed at the beginning of each week and will be applied twice daily, by the subject, during the 3 week treatment phase.
Group II: Desonide GroupActive Control1 Intervention
Group randomly receiving desonide cream as the treatment cream for 3 weeks. Fifteen (15) gram tubes are dispensed at the beginning of each week and will be applied twice daily, by the subject, during the 3 week treatment phase.

Find a Location

Who is running the clinical trial?

NeoStrata Company, Inc.Lead Sponsor
4 Previous Clinical Trials
125 Total Patients Enrolled
Massachusetts General HospitalOTHER
2,928 Previous Clinical Trials
13,198,313 Total Patients Enrolled
Alexandra Kimball, MDPrincipal InvestigatorMassachusetts General Hospital: Clinical Unit for Research Trials in Skin

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Skin Effects of a Topical Amino Acid Moisturizing Cream and Desonide in Atopic Dermatitis
2014. "Skin Effects of a Topical Amino Acid Moisturizing Cream and Desonide in Atopic Dermatitis". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT02286700.
All > Seborrheic Dermatitis > Atopic Dermatitis
~4 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top